We are very pleased to announce that Dr. Brian Jahns, Vice-President, Sales and Marketing, Oncology at Hoffmann-La Roche has agreed to speak at our LSC2011!
Dr. Jahns is a pharmaceutical industry leader with extensive accomplishments in marketing strategy, field force effectiveness, and team development. In the past several years, he has fulfilled various marketing, sales management, and medical roles at Roche, most recently as the Business Unit Director for Hematology. He has participated in the successful launch and growth of several antiviral agents, transplant immunosuppressants and anti-cancer biologics. Throughout the decade prior to joining Roche, he was a consultant to the Canadian pharmaceutical industry, and was involved in academia and the delivery of patient care at the University of Toronto and several institutions in the United States.
F. Hoffmann-La Roche Ltd. is a Fortune 500 healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. The company also owns the American biotechnology company Genentech, which is a wholly owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals as well as the Tucson, Arizona based Ventana.
As a research-focused healthcare company, Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals - from early detection and prevention of diseases to diagnosis, treatment, and treatment monitoring. Roche employs over 80,000 people and sells its products in over 150 countries.
